Does Dr. MOHIT AGARWAL have financial conflicts of interest?

Dr. MOHIT AGARWAL (MD) has received a total of $3,417 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,417 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MOHIT AGARWAL?

According to CMS Open Payments data, Dr. MOHIT AGARWAL received funding from OTSUKA AMERICA PHARMACEUTICAL ($346), OPKO PHARMACEUTICALS ($315), and ASTRAZENECA PHARMACEUTICALS ($277).

Does Dr. MOHIT AGARWAL receive research grants or speaking fees?

Dr. MOHIT AGARWAL has received $3,417 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MOHIT AGARWAL

MDReal-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: PHOENIX, AZ 85004

NPI Number: 1407061781

LIFETIME INDUSTRY VALUE

$3,417

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AGARWAL is a verified Internal Medicine, Nephrology practitioner based in PHOENIX, AZ.

Between 2021 and 2024, Dr. AGARWAL had an overall industry promotional and research financial footprint of $3,417 as recorded in the federal CMS Open Payments database.

$3,417 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGARWAL's primary funding source is OTSUKA AMERICA PHARMACEUTICAL, which accounts for $346 (representing 10.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OTSUKA AMERICA PHARMACEUTICAL

Rank 1

$346

10.1%

OPKO PHARMACEUTICALS

Rank 2

$315

9.2%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$277

8.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.